News & Events

EntroGen, Inc., a leading provider of molecular diagnostic solutions in oncology, today announced the launch of its Microsatellite Instability (MSI) Detection Kit (RUO) — a modern PCR-based assay designed to deliver fast, reliable MSI detection with a streamlined...

Missed us at CDx or you want to learn more.Fill out the form below.EntroGen is honored to participate in the 15th World Clinical Biomarkers & Companion Diagnostics Summit in Boston, taking place September 22-25. Dr. Gary Potikyan, EntroGen’s Chief...

EntroGen is pleased to announce its participation in the 2025 Great Lakes Genomic Conference (GLGC), taking place on Friday, May 16, 2025, at the Peter Gilgan Centre for Research and Learning in Toronto, Ontario. As part of our ongoing commitment to advancing...

Apr 28, 2025 – EntroGen announced today that its CRCdx® RAS Mutation Detection Kit has received national coverage from the US Centers for Medicare & Medicaid Services (CMS).

EntroGen will be exhibiting at the ESMO Congress 2023 in Madrid, Spain on October 20-23, 2023. Visit EntroGen at Booth 709, Hall 7.

November 14-18, 2023. Visit booth #924.

October 2, 2023 – The U.S. Food and Drug Administration (FDA) has granted approval for EntroGen’s CRCdx® RAS Mutation Detection Kit as a companion diagnostic for Vectibix® (panitumumab), a targeted therapy used in the treatment of colorectal cancer.

October 12, 2022 11am PDT | 2pm EDT

Nov 1-5, 2022

January 27, 2022 11am PST | 2pm EST